Wencai Ma
First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Acute Myeloid Leukemia Research, Gene expression and cancer classification, Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics
Most-Cited Works
- → Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade(2016)1,002 cited
- → Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial(2013)529 cited
- → Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion(2013)446 cited
- → Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality(2019)342 cited
- → Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance(2014)266 cited
- → ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies(2016)199 cited
- → A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily(2018)189 cited
- → Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia(2022)173 cited
- → Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma(2012)172 cited
- → Edge-based scoring and searching method for identifying condition-responsive protein–protein interaction sub-network(2007)140 cited